Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice (Q34372342)

1 August 2017

Generation of orthotopic and heterotopic human pancreatic cancer xenografts in immunodeficient mice (English)

1 reference

1 August 2017

1 reference

1 reference

5

Jason B Fleming

1 reference

1 August 2017

3

Huamin Wang

1 reference

1 August 2017

James Lewis Abbruzzese

series ordinal

4

object named as

James L Abbruzzese

1 reference

1 August 2017

Michael P Kim

1

1 reference

1 August 2017

Douglas B Evans

series ordinal

2

1 reference

1 August 2017

Gary E Gallick

series ordinal

6

1 reference

1 August 2017

29 October 2009

1 reference

1 August 2017

1 reference

1 August 2017

4

1 reference

1 August 2017

1670-1680

1 reference

1 August 2017

11

1 reference

https://scigraph.springernature.com/pub.10.1038/nprot.2009.171

1 August 2017

0 references

cites work

Efficient tumour formation by single human melanoma cells

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

Direct in vivo xenograft tumor model for predicting chemotherapeutic drug response in cancer patients

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

Core signaling pathways in human pancreatic cancers revealed by global genomic analyses

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

Maximizing mouse cancer models

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

Identification of pancreatic cancer stem cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

A human colon cancer cell capable of initiating tumour growth in immunodeficient mice

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

The use of targeted mouse models for preclinical testing of novel cancer therapeutics.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

The mighty mouse: genetically engineered mouse models in cancer drug development

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

Orthotopic transplantation models of pancreatic adenocarcinoma derived from cell lines and primary tumors and displaying varying metastatic activity

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

Integrating pharmacology and in vivo cancer models in preclinical and clinical drug development

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

Phase III trial of gemcitabine plus tipifarnib compared with gemcitabine plus placebo in advanced pancreatic cancer

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

Clinical predictive value of the in vitro cell line, human xenograft, and mouse allograft preclinical cancer models

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

Prospective identification of tumorigenic breast cancer cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

NOD/SCID/gamma(c)(null) mouse: an excellent recipient mouse model for engraftment of human cells

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

Relationships between drug activity in NCI preclinical in vitro and in vivo models and early clinical trials

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

Characterization of the antitumor effects of the selective farnesyl protein transferase inhibitor R115777 in vivo and in vitro.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

A severe combined immunodeficiency mutation in the mouse

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

Establishment of patient-derived non-small cell lung cancer xenografts as models for the identification of predictive biomarkers.

6 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

The pediatric preclinical testing program: description of models and early testing results.

27 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4203372

Opinion: Comparative biology of mouse versus human cells: modelling human cancer in mice

27 October 2018

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.171

A metastatic nude-mouse model of human pancreatic cancer constructed orthotopically with histologically intact patient specimens

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.171

An in vivo platform for translational drug development in pancreatic cancer

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.171

‘Nude’, a new hairless gene with pleiotropic effects in the mouse

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.171

Inhibition of SRC expression and activity inhibits tumor progression and metastasis of human pancreatic adenocarcinoma cells in an orthotopic nude mouse model

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.171

Neuropilin-1 suppresses tumorigenic properties in a human pancreatic adenocarcinoma cell line lacking neuropilin-1 coreceptors

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.171

From human to mouse and back: 'tumorgraft' models surge in popularity

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.171

Orthotopic metastatic mouse models for anticancer drug discovery and evaluation: a bridge to the clinic

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.171

In vivo selection and characterization of metastatic variants from human pancreatic adenocarcinoma by using orthotopic implantation in nude mice

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.171

Nuclear factor-kappaB maintains TRAIL resistance in human pancreatic cancer cells

31 March 2020

1 reference

https://api.crossref.org/works/10.1038%2FNPROT.2009.171

31 March 2020

Identifiers

DOI

10.1038/NPROT.2009.171

1 reference

Dimensions Publication ID

1 August 2017

0 references

1 reference

1 August 2017

1 reference